Advertisement
Research Article| Volume 36, SUPPLEMENT 1, S23-S26, September 2010

Download started.

Ok

Improving quality of cancer care through surgical audit

  • W. van Gijn
    Affiliations
    Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    Search for articles by this author
  • C.J.H. van de Velde
    Correspondence
    Corresponding author. Leiden University Medical Center, Department of Surgery, K6-R, P.O. Box 9600, 2300 RC Leiden, The Netherlands. Tel.: +31 71 526 2309; fax: +31 71 526 6750.
    Affiliations
    Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands
    Search for articles by this author
  • on behalf of the members of the EURECCA consortium
    Author Footnotes
    1 A. Dziki, Medical University of Lodz, PolandE.H. Eddes, Dutch Surgical Colorectal Audit, The NetherlandsS. Laurberg, Danish Colorectal Cancer Database, DenmarkP. Mroczkowski, University of Magdeburg, GermanyH. Ortiz, Universidad Pública de Navarra, SpainL. Pahlman, Swedish Colorectal Cancer Registration, SwedenD. Pavalkis, Kaunas University of Medicine, LithuaniaF. Penninckx, Belgian Cancer Registry [PROCARE], BelgiumG. Romano, National Cancer Institute of Naples, ItalyJ. Smith, National Bowel Cancer Programme, United KingdomV. Valentini, Università Cattolica S. Cuore, Rome, ItalyC.J.H. van de Velde, Leiden University Medical Center, The NetherlandsA. Wibe, Norwegian Colorectal Cancer Registry, Norway.
  • Author Footnotes
    1 A. Dziki, Medical University of Lodz, PolandE.H. Eddes, Dutch Surgical Colorectal Audit, The NetherlandsS. Laurberg, Danish Colorectal Cancer Database, DenmarkP. Mroczkowski, University of Magdeburg, GermanyH. Ortiz, Universidad Pública de Navarra, SpainL. Pahlman, Swedish Colorectal Cancer Registration, SwedenD. Pavalkis, Kaunas University of Medicine, LithuaniaF. Penninckx, Belgian Cancer Registry [PROCARE], BelgiumG. Romano, National Cancer Institute of Naples, ItalyJ. Smith, National Bowel Cancer Programme, United KingdomV. Valentini, Università Cattolica S. Cuore, Rome, ItalyC.J.H. van de Velde, Leiden University Medical Center, The NetherlandsA. Wibe, Norwegian Colorectal Cancer Registry, Norway.

      Abstract

      Quality of healthcare is a hot topic and this is especially true for cancer care. New surgical techniques and effective neoadjuvant treatment regimens have significantly improved colorectal cancer outcome. Nevertheless, there seem to be substantial differences in quality of care between European countries, hospitals and doctors. To reduce hospital variation, most initiatives aim on selective referral, encouraging patients to seek care in high-volume hospitals, where cancer care is concentrated to site-specialist multidisciplinary teams. As an alternative to volume-based referral, hospitals and surgeons can also improve their results by learning from their own outcome statistics and those from colleagues treating a similar patient group. European national audit registries in surgical oncology have led to improvements with a greater impact on survival than any of the adjuvant therapies currently under study. Moreover, they offer the possibility to perform research on patient groups that are usually excluded from clinical trials.
      Nevertheless, between European countries remain differences in outcome and treatment schedules that cannot be easily explained. The European CanCer Organisation (ECCO) has recognised these importances and created the ‘European Registration of Cancer Care’ (EURECCA) framework to develop a European colorectal audit structure. EURECCA will advance future treatment improvements and spread these to all European cancer patients. It provides opportunities to treat elderly and comorbid patients evidence based while it offers an unique insight in social-economical healthcare matters such as the consequences of commercialisation, treatment availability and screening initiatives. As such, ECCO has established the basis for a strong, multidisciplinary audit structure with the commitment to improve cancer care for every European cancer patient.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Surgical Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Sant M.
        • Allemani C.
        • Santaquilani M.
        • et al.
        EUROCARE-4. Survival of cancer patients diagnosed in 1995–1999. Results and commentary.
        Eur J Cancer. 2009; 45: 931-991
        • Birkmeyer J.D.
        • Finlayson E.V.
        • Birkmeyer C.M.
        Volume standards for high-risk surgical procedures: potential benefits of the leapfrog initiative.
        Surgery. 2001; 130: 415-422
        • McCulloch P.
        Surgical professionalism in the 21st century.
        Lancet. 2006; 367: 177-181
        • Gatta G.
        • Faivre J.
        • Capocaccia R.
        • et al.
        Survival of colorectal cancer patients in Europe during the period 1978–1989.
        Eur J Cancer. 1998; 34: 2176-2183
        • Heald R.J.
        • Husband E.M.
        • Ryall R.D.
        The mesorectum in rectal cancer surgery – the clue to pelvic recurrence?.
        Br J Surg. 1982; 69: 613-616
        • Heald R.J.
        • Ryall R.D.
        Recurrence and survival after total mesorectal excision for rectal cancer.
        Lancet. 1986; 1: 1479-1482
        • MacFarlane J.K.
        • Ryall R.D.
        • Heald R.J.
        Mesorectal excision for rectal cancer.
        Lancet. 1993; 341: 457-460
        • Wibe A.
        • Moller B.
        • Norstein J.
        • et al.
        A national strategic change in treatment policy for rectal cancer – implementation of total mesorectal excision as routine treatment in Norway. A national Audit.
        Dis Colon Rectum. 2002; 45: 857-866
      1. Wibe A. Nationwide quality Assurance of rectal cancer treatment. In: Colorectal congress. 28th November 2007, St. Gallen, Switzerland; 2007.

        • Pahlman L.
        • Bohe M.
        • Cedermark B.
        • et al.
        The Swedish Rectal Cancer Registry.
        Br J Surg. 2007; 94: 1285-1292
        • Birgisson H.
        • Talback M.
        • Gunnarsson U.
        • et al.
        Improved survival in cancer of the colon and rectum in Sweden.
        Eur J Surg Oncol. 2005; 31: 845-853
        • Harling H.
        • Bulow S.
        • Kronborg O.
        • et al.
        Survival of rectal cancer patients in Denmark during 1994–99.
        Colorectal Dis. 2004; 6: 153-157
      2. Report of The National Bowel Cancer Audit Programme “NBOCAP Report 2009”. http://www.nbocap.org.uk/resources/reports/NBOCAP_2009.pdf.

        • Mroczkowski P.
        • Kube R.
        • Schmidt U.
        • et al.
        Quality assessment of colorectal cancer care – an international online model.
        Colorectal Dis. 2010;
        • Penninckx F.
        • Van E.L.
        • Michiels G.
        • et al.
        Survival of rectal cancer patients in Belgium 1997–98 and the potential benefit of a national project.
        Acta Chir Belg. 2006; 106: 149-157
      3. PROCARE: Global Results.
        2009
      4. Spanish TME Project.
        2006–2008
      5. Dutch Surgical Colorectal Audit: Report.
        2009